Research progress of transcription factor AP-2 γ in malignant tumors

doi:10.16352/j.issn.1001-6325.2022.12.1955

Abstract

Abstract: Transcription factor AP-2γ regulates not only the genetic procedures that control the proliferation and differentiation of trophoblast cells during early embryonic development, but also is the key target in the development of breast cancer, lung cancer, testicular cancer, melanoma and pancreatic cancer, thus affecting the occurrence and development of tumors. Therefore, paying attention to the regulatory mechanisms of AP-2γ in the occurrence and development of malignant tumors may provide new ideas for the diagnosis and treatment of tumors.

Key words: transcription factor, AP-2γ, embryonic development, tumor

CLC Number:

R730.53

CHEN Kang, CHENG Fan. Research progress of transcription factor AP-2 γ in malignant tumors[J]. Basic & Clinical Medicine, 2022, 42(12): 1955-1959.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.12.1955

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I12/1955

References

[1]齐力,候艳,宋丽华. 转录因子YY1促进下咽癌细胞的迁移能力[J]. 基础医学与临床,2019,39:1320-1324.
[2]Dooley CM, Wali N, Sealy IM, et al. The gene regulatory basis of genetic compensation during neural crest induction[J]. PLoS Genet, 2019, 15:e1008213.doi: 10.1371/journal.pgen.1008213.
[3]Kołat D, Kałuzińskaz, Bednarek AK, et al. WWOX loses the ability to regulate oncogenic Ap-2γ and synergizes with tumor suppressor AP-2α in high-grade bladder cancer[J]. Cancers, 2021, 13:2957.doi: 10.3390/cancers13122957.
[4]Kołat D, Kałuzińskaz, Bednarek AK, et al. The biol-ogical characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers[J]. Biosci Rep, 2019, 39:BSR20181928.doi: 10.1042/BSR20181928.
[5]Li L, Wang Y, Torkelson JL, et al. TFAP2C- and p63-dependent networks sequentially rearrange chromatin landscapes to drive human epidermal lineage commitment[J]. Cell Stem Cell, 2019, 24:271-284.doi: 10.1016/j.stem.2018.12.012.
[6]Wang Y, Chen S, Jiang Q, et al. TFAP2C facilitates somatic cell reprogramming by inhibiting c-Myc-dependent apoptosis and promoting mesenchymal-to-epithelial transition[J]. Cell Death Dis, 2020, 11:482.doi: 10.1038/s41419-020-2684-9.
[7]Kołat D, Kałuzińskaz, Płuciennik E. Fragile gene WWOX guides TFAP2A/TFAP2C-dependent actions against tumor progression in grade ii bladder cancer[J]. Front Oncol, 2021, 11:621060.doi: 10.3389/fonc.2021.621060.
[8]Li H, Goswami PC, Domann FE. AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells[J]. Neoplasia, 2006, 8:568-577.
[9]Franke CM, Gu VW, Grimm BG, et al. TFAP2C regu-lates carbonic anhydrase XII in human breast cancer[J]. Oncogene, 2020, 39:1290-1301.
[10]Wu VT, Kiriazov B, Koch KE, et al. A TFAP2C gene signature is predictive of outcome in HER2-positive breast cancer[J]. Mol Cancer Res, 2020, 18:46-56.
[11]Park JM, Wu T, Cyr AR, et al. The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis[J]. Oncogene, 2015, 34:6105-6114.
[12]Li K, Xu C, Du Y, et al. Comprehensive epigenetic analyses reveal master regulators driving lung metastasis of breast cancer[J]. J Cell Mol Med, 2019, 23:5415-5431.
[13]Vernieri C, Milano M, Brambilla M, et al. Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: current knowledge, new research direc-tions and therapeutic perspectives[J]. Crit Rev Oncol Hematol, 2019, 139:53-66.
[14]Cheng C, Ai Z, Zhao L. Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma[J]. Genes Genom, 2020, 42:779-789.
[15]Do H, Kim D, Kang J, et al. TFAP2C increases cell proliferation by downregulating GADD45B and PMAIP1 in non-small cell lung cancer cells[J]. Biol Res, 2019, 52:35.doi: 10.1186/s40659-019-0244-5.
[16]Kim W, Kim E, Lee S, et al. TFAP2C-mediated upregulation of TGFBR1 promotes lung tumorigenesis and epithelial-mesenchymal transition[J]. Exp Mol Med, 2016, 48:e273.doi: 10.1038/emm.2016.125.
[17]Lal G, Contreras PG, Kulak M, et al. Human melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C[J]. PLoS One, 2013, 8:e73953.doi: 10.1371/journal.pone.0073953.
[18]Penna E, Orso F, Cimino D, et al. MicroRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C[J]. Embo j, 2011, 30:1990-2007.
[19]Chang WF, Peng M, Hsu J, et al. Effects of survival motor neuron protein on germ cell development in mouse and human[J]. Int J Mol Sci, 2021, 22:661.doi: 10.3390/ijms22020661.
[20]Senft AD, Bikoff EK, Robertson EJ, et al. Genetic dissection of Nodal and Bmp signalling requirements during primordial germ cell development in mouse[J]. Nat Commun, 2019, 10:1089.doi: 10.1038/s41467-019-09052-w.
[21]Xiong G, Huang H, Feng M, et al. miR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma[J]. J Exp Clin Cancer Res, 2018, 37:76.doi: 10.1186/s13046-018-0739-x.
[22]Li L, Zheng YL, Jiang C, et al. HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma[J]. Cell Death Differ, 2019, 26:2268-2283.
[23]Lin CY, Lee LY, Wang TH, et al. Palbociclib promotes dephosphorylation of NPM/B23 at threonine 199 and inhibits endometrial cancer cell growth[J]. Cancers, 2019, 11:1025.doi: 10.3390/cancers11071025.
[24]Bardelli V, Arniani S, Pierini V, et al. T-cell acute lymphoblastic leukemia: biomarkers and their clinical usefulness[J]. Genes, 2021, 12:1118.doi: 10.3390/genes12081118.
[25]Zhuang M, Chaolumen Q, Li L, et al. miR-29b-3p cooperates with miR-29c-3p to affect the malignant biological behaviors in T-cell acute lymphoblastic leukemia via TFAP2C/GPX1 axis[J]. Biochem Biophys Res Commun, 2020, 527:511-517.